This morning, as stocks declined because of fears of continued rate back-up, the high-growth portfolio made some changes. It eliminated the last of the Unity position-not because of any specific news or change in expectations, but simply because of my expectations that with the rather substantial drawdowns in shares of Nebius and Cerebras in the last couple…
Given the spike in Nebius which had carried the portfolio weight to about 16.5% the high growth portfolio trimmed about 15% of its position or 300 shares. The shares were sold at $269.99 and the new portfolio weight is 13.93%. The sale raised $80,990. The portfolio now has 1850 share of Nebius, still the largest holding Cerebras shares…
Most of Ticker Target’s subscribers own a position in Nebius shares. In many cases, Nebius is their largest single holding. That is true, as well, for the Ticker Target high growth portfolio. So, I wanted to review a few observations regarding the company’s earnings release. I encourage readers who want answers to some specific questions…
Shares of Snowflake continued to spike and we have sold half of the remaining position (250 shares) at $314.01. The sale raised approximately $78,490. The remaining Snowflake position in the high growth portfolio is 250 shares and that has a weight of 2.79% in the high growth portfolio. If the shares continue to spike, we…
Simply put-No! I am neither prescient nor gifted with second sight. And when there is nothing to see, I can’t see it. Nebius shares are down by more than 37% in little more than a week. The precipitating factor has been the rumor that Meta is set to become a competitor in the AI infrastructure space. This…
a) Cerebras Cerebras shares have fallen by around 4% today. It is a very volatile stock that often moves without a great deal of substantive information. A few days ago it appreciated as much as 20% after it announced that it was building data centers in Europe at an accelerated pace. Today the shares have fallen…
We wrote about adding to the Nebius position and starting a position in Cerebras shares in the weekly commentary. Since the commentary won’t be published for a few hours, here is what I wrote about both companies. Nebius: did last week’s drawdown make sense? Cerebras: is this a bet worth taking? a) Nebius Last week…
Overnight, Nebius sent notices to its customers regarding a price increase as follows: The price for on-demand (PAYG) capacity will increase by an average 29%, and the price for preemptible (PVM) capacity will increase by 51%. The hike does not apply to existing customers. NBIS Reportedly Sees Record Demand “This update reflects continued strong demand…
The High Growth portfolio added to its minimal position in TempusAI shares. 500 shares were added at a price of $42.79 which cost $21, 405. We now have 750 shares of Tempus which has a weight of 1.38% in the high growth portfolio. We may add to the position to get the weight to a reasonable level.…
Nebius reported a particularly strong quarter earlier today-one of solid execution on all major fronts. While it reaffirmed it 2026 targets for revenue, ending ARR and margins, there were some metrics, particularly that of year-end capacity in terms of power (the company is now forecasting 4 GW up from 3 GW of contracted power at…